Nektar Therapeutics trailing returns
Nektar Therapeutics's 10-year return is -15.3% a year (CAGR) (-81.0% cumulative). How Nektar Therapeutics (NKTR) has performed over the last day, week, month and year, over 5, 10, 20 and 30 years, and since inception, through October 20, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
To 2026-10-20. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| 1 day | +7.0% | +0.0% | +7.0% | — |
| 5 days | +3.4% | +0.0% | +3.4% | -5.6%Oct 16 |
| 1 month | -41.5% | +0.0% | -41.5% | -46.7%Oct 16 |
| YTD | -7.2% | +0.0% | -7.2% | -64.3%Oct 16 |
| 1 year | -37.7% | +0.0% | -37.7% | -64.3%Oct 2026 |
| 5 years | -30.6% | +0.0% | -30.6%-83.9% | -97.5%Nov 2023 |
| 10 years | -15.3% | +0.0% | -15.3%-81.0% | -99.6%Nov 2023 |
| 20 years | -8.4% | +0.0% | -8.4%-82.8% | -99.6%Nov 2023 |
| 30 years | -3.8% | +0.0% | -3.8%-68.9% | -99.6%Nov 2023 |
| Since inception (1994) | -1.1% | +0.0% | -1.1%-30.3% | -99.6%Nov 2023 |
Growth of NKTR#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- 5 years-30.6%/year · -83.9%
- 10 years-15.3%/year · -81.0%
- 20 years-8.4%/year · -82.8%
- 30 years-3.8%/year · -68.9%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-20). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in NKTR's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Nektar Therapeutics's 10-year return?
- Over the last 10 years, Nektar Therapeutics (NKTR) returned about -15.3% a year annualized (-81.0% cumulative total return).
- What is Nektar Therapeutics's 20-year annualized return?
- Over the last 20 years, Nektar Therapeutics (NKTR) compounded at about -8.4% a year (-82.8% cumulative).
- What is Nektar Therapeutics's 30-year annualized return?
- Over the last 30 years, Nektar Therapeutics (NKTR) compounded at about -3.8% a year (-68.9% cumulative).
- What is Nektar Therapeutics's return since inception?
- Since 1994, Nektar Therapeutics (NKTR) has compounded at about -1.1% a year — -30.3% in total.